within Pharmacolibrary.Drugs.ATC.J;

model J01CA09
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00018,
    adminDuration  = 600,
    adminMass      = 5000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0135,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0081,
    k12             = 6.3,
    k21             = 6.3
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01CA09</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Azlocillin is a semisynthetic, broad-spectrum penicillin antibiotic of the ureidopenicillin class. It has strong activity against Gram-negative bacteria including Pseudomonas aeruginosa and some Gram-positive organisms. It is typically used for severe infections or hospital-acquired infections. Azlocillin is not widely used today, with its approval status restricted or withdrawn in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single intravenous dose.</p><h4>References</h4><ol><li><p>Voigt, R, et al., &amp; Peiker, G (1988). [The pharmacokinetics of azlocillin after single and multiple intravenous injections during the third trimester]. <i>Zentralblatt fur Gynakologie</i> 110(15) 944–948. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3055753/\">https://pubmed.ncbi.nlm.nih.gov/3055753</a></p></li><li><p>Singlas, E, &amp; Haegel, C (1984). [Clinical pharmacokinetics of azlocillin]. <i>Presse medicale (Paris, France : 1983)</i> 13(13) 788–796. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6231596/\">https://pubmed.ncbi.nlm.nih.gov/6231596</a></p></li><li><p>Naber, KG, &amp; Adam, D (1983). Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose. <i>The Journal of antimicrobial chemotherapy</i> 11 Suppl B 115–120. DOI:<a href=\"https://doi.org/10.1093/jac/11.suppl_b.115\">10.1093/jac/11.suppl_b.115</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6619021/\">https://pubmed.ncbi.nlm.nih.gov/6619021</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01CA09;
